Sector portfolio · VC firm · United States
Pappas Ventures' Biotech portfolio
Pappas Ventures has backed 13 Biotech startups in rounds we track, $784M between them, shown by the stage each has reached. The best-funded is Ultragenyx Pharmaceutical.
Funding by segment
- Series A$443M8
- Series B$342M5
Where they are based
- United States12$674M
- Canada1$110M
United States
CanadaFounded
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M6
- $50M to $250M7
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
9 of 13 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States12
- Canada1
Startups by country, 2 countries in all.
Segment by segment
Series A
8 startups · $443M raised
- MTMirum TherapeuticsUnited States$120M
- RPReneo PharmaceuticalsReneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.United States$105M
- CCuraSenUnited States$55M
Envisia TherapeuticsEnvisia Therapeutics is a biotechnology company based in Research Triangle Park, North Carolina, established in 2013 by Liquidia TUnited States$46M
RibometrixRibometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases.United States$45M
OptherionOptherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment United States$42M- LTLEAD TherapeuticsLEAD Therapeutics is a drug discovery company developing small molecule IND candidates for the treatment of cancer and infectious diseases.United States$20M
- BBoragenUnited States$10M
Series B
5 startups · $342M raised
Milestone PharmaceuticalsMilestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.Canada$110M- 4M4D MolecularUnited States$90M
Lumena PharmaceuticalsLumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.United States$71M
Rotation MedicalRotation Medical develops treatments for rotator cuff disease by reversing disease progression and restoring long-term shoulder function.United States$59M
Cequent PharmaceuticalsCequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.United States$12M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Pappas Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Pappas Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.